ArticleJournal of nanobiotechnology2026
Copper-EGCG nanoreactor orchestrates dual-metabolic assault and self-amplified cuproptosis for immunogenic prostate cancer therapy.
Wenya Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.